Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Cognitive Impairment Clinical Trials

17 recruiting trials for Cognitive Impairment. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
17
Total Trials
17
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT06068361

Diagnostic Evaluation of Dementia with Lewy Bodies Using a Multimodal Approach

Dementia with Lewy body disease (DLB) is the second leading cause of degenerative cognitive disorder after Alzheimer's disease (AD). Its variable clinical expression makes...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 1301 location
RECRUITINGNCT05597410

Shanghai At Risk for Alzheimer's Disease: a Cohort Study

The goal of this cohort study is to estimate the incidence of AD in the first-degree relatives of patients with AD. The main questions it aims to answer are: * cognitive changes...

Sponsor: Ruijin HospitalEnrolling: 34181 location
RECRUITINGNCT05081596

A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI &...

The purpose of the study is to examine the effect of Problem Adaptation Therapy for Pain (PATH-Pain) on cognitive functioning, depression and pain-related disability in 100 older...

Sponsor: Weill Medical College of Cornell UniversityEnrolling: 1001 location
RECRUITINGNCT06448403

Multimodal Assesment of Alzheimer Patients

The goal of this study is to learn more about the changes in the brains of patients with cognitive impairment (MCI) and Alzheimer's Disease (AD). The main questions the study...

Sponsor: Norwegian University of Science and TechnologyEnrolling: 601 location
RECRUITINGNCT06757569

Radialis PET Imager for the Assessment of Neuritic Amyloid Plaque Burden

The standard or usual workup for cognitive impairment, including Alzheimer's Disease, may include brain amyloid PET with PET/CT or PET/MR imaging. Amyloid PET is the standard...

Sponsor: University Health Network, TorontoEnrolling: 1601 location
RECRUITINGNCT05877196

A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses

The goal of this clinical trial is to test 6 months of aerobic exercise in older adults who are 65 years or older and have mild cognitive impairment (MCI) or probable/possible...

Sponsor: Arizona State UniversityEnrolling: 2161 location
RECRUITINGNCT05065450

Amygdala Memory Enhancement

The objective is to understand how amygdala activation affects other medial temporal lobe structures to prioritize long-term memories. The project is relevant to disorders of...

Sponsor: Washington University School of MedicineEnrolling: 901 location
RECRUITINGNCT06596746

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

MARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed longitudinally for...

Sponsor: Casa di Cura San Raffaele CassinoEnrolling: 6001 location
RECRUITINGNCT06852209

Training Cognition With Neurofeedback After Stroke

Post-stroke cognitive impairment (PSCI) is a common source of invisible disability. The actual techniques of cognitive remediation have been reported to have only a small effect,...

Sponsor: University Hospital, BordeauxEnrolling: 201 location
RECRUITINGNCT04184375

Cognitive Stimulation for Elderly Bipolar Patients

Age is a major risk factor for the development of cognitive disorders and neurodegenerative pathologies. Cognitive disorders during the phases of bipolar disease are known to...

Sponsor: Groupe Hospitalier de la Rochelle Ré AunisEnrolling: 401 location
RECRUITINGPhase 2 / Phase 3NCT06191965

MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction

The goal of this double-blind, placebo-controlled randomized clinical trial is to test the effect of 12 weeks of orally administered MitoQ (mitoquinol mesylate) supplementation on...

Sponsor: Mclean HospitalEnrolling: 1003 locations
RECRUITINGPhase 1NCT07226219

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

The purpose of this study is to determine if patients with sickle cell disease (SCD) can consistently take a drug called Methylphenidate (MPH) daily, once a day for 4 weeks to...

Sponsor: St. Jude Children's Research HospitalEnrolling: 721 location
RECRUITINGNCT06312956

Multidimensional Evaluation of Patients' Affected by Obstructive Apnea Syndrome (OSAS) Before and After Ventilotherapy

This observational study aims to evaluate multiple dimensions of health in patients with Obstructive Sleep Apnea Syndrome (OSAS), before and after three weeks of ventilotherapy....

Sponsor: Istituto Auxologico ItalianoEnrolling: 651 location
RECRUITINGNCT06020703

A Study of Healthy Microbiome, Healthy Mind

Researchers are doing this study to find out if a high fermented food diet is tolerable, and if it will help improve quality of life after surviving a critical illness, including...

Sponsor: Mayo ClinicEnrolling: 401 location
RECRUITINGNCT06013579

Effect of High-Intensity Exercise to Attenuate Cognitive Function Limitations and Train Exercise Habits in Older People...

People aging with HIV are at higher risk for Alzheimer's disease and related dementias, and although physical activity is a promising target to mitigate such risk, this population...

Sponsor: University of Alabama at BirminghamEnrolling: 1103 locations
RECRUITINGPhase 2NCT05336201

Cognitive Remediation Intervention to Prepare for Transition of Care

Randomized Controlled Trial (RTC) testing the efficacy of a telehealth adaptation of the Cognitive-Remediation of Executive and Adaptive Deficits in Youth (C-READY) intervention...

Sponsor: University of Alabama at BirminghamEnrolling: 1201 location
RECRUITINGNCT05885295

The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)

Stroke is a major cause of death and disability worldwide, frequently resulting in persistent cognitive deficits among survivors. These deficits negatively impact recovery and...

Sponsor: Imperial College LondonEnrolling: 7001 location